Susquehanna International Group
GH icon

Susquehanna International Group’s Guardant Health GH Stock Holding History

Susquehanna International Group’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$19.5M Sell
211,500
-744,700
-78% -$74.8M ﹤0.01% 2252
2025
Q4 		$97.7M Buy
956,200
+143,800
+18% +$12.9M 0.01% 907
2025
Q3 		$50.8M Buy
812,400
+212,000
+35% +$11.5M 0.01% 1332
2025
Q2 		$31.2M Buy
600,400
+57,000
+10% +$2.55M ﹤0.01% 1576
2025
Q1 		$23.1M Buy
543,400
+128,400
+31% +$5.54M ﹤0.01% 1614
2024
Q4 		$12.7M Buy
415,000
+320,700
+340% +$9.02M ﹤0.01% 2356
2024
Q3 		$2.16M Sell
94,300
-72,200
-43% -$2.04M ﹤0.01% 5121
2024
Q2 		$4.81M Sell
166,500
-159,100
-49% -$3.7M ﹤0.01% 3502
2024
Q1 		$6.72M Buy
325,600
+165,200
+103% +$3.54M ﹤0.01% 3181
2023
Q4 		$4.34M Sell
160,400
-60,400
-27% -$1.58M ﹤0.01% 3945
2023
Q3 		$6.54M Sell
220,800
-50,300
-19% -$1.77M ﹤0.01% 3117
2023
Q2 		$9.71M Sell
271,100
-56,400
-17% -$1.62M ﹤0.01% 2535
2023
Q1 		$7.68M Sell
327,500
-13,200
-4% -$377K ﹤0.01% 2833
2022
Q4 		$9.27M Sell
340,700
-19,800
-5% -$906K ﹤0.01% 2371
2022
Q3 		$19.4M Buy
360,500
+79,800
+28% +$4.1M 0.01% 1450
2022
Q2 		$11.3M Buy
280,700
+250,800
+839% +$12.4M ﹤0.01% 2042
2022
Q1 		$1.98M Sell
29,900
-108,400
-78% -$7.42M ﹤0.01% 5508
2021
Q4 		$13.8M Buy
138,300
+3,800
+3% +$393K ﹤0.01% 2280
2021
Q3 		$16.8M Sell
134,500
-25,200
-16% -$2.99M ﹤0.01% 2170
2021
Q2 		$19.8M Sell
159,700
-29,400
-16% -$3.95M ﹤0.01% 2046
2021
Q1 		$28.9M Sell
189,100
-2,400
-1% -$363K ﹤0.01% 1509
2020
Q4 		$24.7M Sell
191,500
-7,100
-4% -$817K ﹤0.01% 1515
2020
Q3 		$22.2M Buy
198,600
+78,600
+66% +$7.19M ﹤0.01% 1397
2020
Q2 		$9.74M Sell
120,000
-95,000
-44% -$7.65M ﹤0.01% 2168
2020
Q1 		$15M Buy
215,000
+116,700
+119% +$8.96M ﹤0.01% 1393
2019
Q4 		$7.68M Sell
98,300
-83,800
-46% -$6.04M ﹤0.01% 2399
2019
Q3 		$11.6M Buy
182,100
+46,400
+34% +$4.09M ﹤0.01% 1817
2019
Q2 		$11.7M Buy
135,700
+60,400
+80% +$4.61M ﹤0.01% 1736
2019
Q1 		$5.78M Buy
+75,300
New +$4.17M ﹤0.01% 2302

Other funds holding GH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group's GH Position: Q1 2026 in Review

Susquehanna International Group increased its Guardant Health (GH) stake by 2,199% in Q1 2026, buying an estimated $7.3M and bringing the position to 75,989 shares worth $7.02M. The position accounts for ﹤0.01% of the portfolio, ranked #3657.

Susquehanna International Group first reported a position in GH in Q1 2019 and has held it in 27 quarters since. The position peaked at $15.5M in Q2 2020. 482 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • Susquehanna International Group held 75,989 shares of Guardant Health worth $7.02M as of Q1 2026.
  • Susquehanna International Group bought 72,683 Guardant Health shares in Q1 2026, an estimated $7.3M.
  • Guardant Health made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #3657 holding.
  • Susquehanna International Group first reported a position in Guardant Health in Q1 2019 and has held it in 27 quarters since.
  • Susquehanna International Group's Guardant Health position peaked at $15.5M in Q2 2020.
  • 482 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.